ArticleEuropean heart journal. Digital health2026
Retinal photographs to predict life's essential 8 for cardiovascular risk stratification: a novel deep-learning-based tool.
Article in European heart journal. Digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Both Life's essential 8 (LE8) and retinal photographs are closely related to cardiovascular diseases (CVDs). We aimed to develop a novel deep learning-based tool for CVD risk stratification, termed RetiLE8, by predicting LE8 based on retinal photographs. Methods and results: This study was based on the UK Biobank, a prospective cohort study. Retinal photographs from the UK Biobank were used to train a deep learning model to predict LE8 scores, generating the RetiLE8 scores. Cox proportional hazards models were used to estimate the association of RetiLE8 with all-cause mortality, CVD mortality, and CVD events. Model performance was compared with that of LE8 and the Pooled Cohort Equations (PCE), a contemporary risk estimation tool, using Harrell's concordance index (C-index) and continuous net reclassification improvement (NRI). Retinal photographs from 10 798 participants and 25 750 participants of the UK Biobank were utilized for the development and validation of RetiLE8, respectively. RetiLE8 showed a modest correlation with LE8. One standard deviation (SD) increase in the RetiLE8 score was associated with 13% (95% CI, 7-19%) lower all-cause mortality risk and 10% (4-14%) lower CVD event risk, independent of the LE8 score and covariates. The RetiLE8 score showed similar discrimination to the LE8 score and the PCE in predicting outcomes and significantly improved risk stratification beyond both tools. Conclusion: The RetiLE8 score may serve as a complementary tool for CVD risk stratification with existing tools. Prospective studies implementing this tool in clinical practice are warranted to evaluate its utility in real-world settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.